Almirall S.A. Logo

Almirall S.A.

Global biopharmaceutical company specializing in medical dermatology and skin health.

ALM | MC

Overview

Corporate Details

ISIN(s):
ES0157097017
LEI:
95980020140005007996
Country:
Spain
Address:
Ronda General Mitre 151, 08022 Barcelona

Description

Almirall S.A. is a global biopharmaceutical company specializing in medical dermatology. The company focuses on the research, development, manufacturing, and commercialization of proprietary medicines to address significant unmet needs in skin health. Leveraging scientific innovation, Almirall provides medical solutions designed to improve the well-being and quality of life for patients. Its operations encompass in-house research and development, strategic partnerships, and in-licensing to expand its portfolio of dermatological treatments.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-17 18:19
Almirall ha procedido al cierre y desembolso de su emisión de obligaciones simp…
Spanish 184.0 KB
2025-05-12 07:33
Información sobre el calendario del dividendo
Spanish 104.4 KB
2025-05-12 07:23
Información sobre dividendos
Spanish 188.2 KB
2025-05-12 07:15
Acuerdos adoptados por el Consejo de Administración
Spanish 105.9 KB
2025-05-12 07:04
Acuerdos adoptados por la Junta General de Accionistas 2025
Spanish 182.9 KB
2025-05-12 06:57
Almirall remite presentación sobre los resultados del primer trimestre de 2025 …
Spanish 1.3 MB
2025-05-12 06:51
Almirall realizará una presentación vía webcast para explicar los Resultados de…
Spanish 101.3 KB
2025-05-12 00:00
Acuerdos adoptados por la Junta General de Accionistas 2025
Spanish 182.9 KB
2025-04-09 11:58
Operaciones del contrato de liquidez durante el primer trimestre de 2025
English 187.4 KB
2025-04-01 13:17
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025 -…
Spanish 279.9 KB
2025-04-01 00:00
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025 -…
Spanish 279.9 KB
2025-03-31 17:58
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025
Spanish 141.0 KB
2025-03-31 00:00
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025
Spanish 141.0 KB
2025-03-06 07:28
Almirall anuncia el plan de transición del CFO
Spanish 72.6 KB
2025-02-24 06:43
La sociedad remite presentación sobre los resultados del ejercicio 2024
Spanish 1.3 MB

Automate Your Workflow. Get a real-time feed of all Almirall S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Almirall S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Almirall S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Benitec Biopharma Inc. Logo
A clinical-stage biotech developing genetic medicines to silence disease-causing genes.
United States of America
BNTC
BeOne Medicines Ltd. Logo
Global oncology company that discovers, develops, and delivers cancer treatments.
United States of America
ONC
BerGenBio Logo
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
Norway
BGBIO
Beximco Pharmaceuticals Ltd. Logo
Manufacturer of generic drugs, APIs, and specialized products for global markets.
Bangladesh
BXP
BeyondSpring Inc. Logo
Clinical-stage biopharma company developing immuno-oncology cancer therapies.
United States of America
BYSI
BGM Group Ltd. Logo
A holding company focused on technology and biopharmaceutical manufacturing.
United States of America
BGM
Bicara Therapeutics Inc. Logo
Clinical-stage biopharma developing dual-action biologics for solid tumors.
United States of America
BCAX
BICYCLE THERAPEUTICS PLC Logo
Clinical-stage biopharma developing a novel class of bicyclic peptide medicines.
United States of America
BCYC
BIFIDO. Co. Ltd Logo
Biotechnology firm developing human-derived Bifidobacterium for various products.
South Korea
238200
Binex Co., Ltd. Logo
Biopharmaceutical firm with pharma manufacturing and biologics CDMO services.
South Korea
053030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.